Group 1 - The 2025 Taihu Bay Life and Health Future Conference was held in Wuxi, focusing on "Digital Intelligence Empowerment for a Healthy Future" [1] - AstraZeneca, in collaboration with Wuxi High-tech Zone and Ruijin Hospital Yangtze River Delta Health Research Institute, launched the "Ruijin Yangtze River Delta Metabolic Industry Park" [1] - The newly established "Yangtze River Delta AI Biomedicine Industry Alliance" aims to accelerate the integration of AI and biomedicine, creating a nationally influential innovation platform [1] Group 2 - AstraZeneca's China General Manager emphasized Wuxi as a strategic hub for the company's operations in China, focusing on scientific innovation and sustainable development [2] - The company plans to deepen its presence in China, promoting international cooperation and contributing to the Healthy China 2030 initiative [2]